Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02566070 · ClinicalTrials.gov registry record · NA
COntinuous vs BOlus Nasogastric Feeding in Mechanically Ventilated Pediatric Patients 2
A NA study, sponsored by Akron Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 147
- Enrollment target
NCT02566070: Completed NA study, sponsored by Akron Children's Hospital.
NCT02566070 is a NA study that has completed, run by Akron Children's Hospital. The registered enrollment target is 147 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02566070, a NA study, has completed, sponsored by Akron Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 147 participants
- Enrollment target
Study Summary
This multi-center, prospective, randomized comparative effectiveness intervention study will evaluate continuous feeding (CGF) and bolus gastric feeding (BGF) protocols and their effect on delivery of prescribed nutrition and feeding intolerance in mechanically ventilated critically ill children for up through 12 hours post achievement goal feeds or exclusion from feeding protocol, whichever comes first, to a maximum of 10 days.
Primary Outcome
TTGF defined as time to attain goal feeds
Interventions
- OTHER Continuous Gastric Feeding
- OTHER Bolus Gastric Feeding
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT02566070 record still lists
NCT02566070 is an interventional study that assigns participants to a tested intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Continuous Gastric Feeding is the first listed.
NCT02566070 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02566070 about?
NCT02566070 is a clinical study titled "COntinuous vs BOlus Nasogastric Feeding in Mechanically Ventilated Pediatric Patients 2". This multi-center, prospective, randomized comparative effectiveness intervention study will evaluate continuous feeding (CGF) and bolus gastric feeding (BGF) protocols and their effect on delivery of prescribed nutrition and feeding intolerance in mechanically ventilated critically ill children for...
What is the current status of trial NCT02566070?
This trial is currently completed. It is a NA study. The enrollment target is 147 participants. The study started on 2015-11. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02566070?
The interventions under investigation include: Continuous Gastric Feeding (OTHER), Bolus Gastric Feeding (OTHER).
Who is sponsoring clinical trial NCT02566070?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02566070's enrollment target sits among peer trials
147 703rd of 2000 higher than 1,297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04396613 · 147 participants · NA
Wound Closure Techniques in Primary Spine Surgery
- NCT04851119 · 147 participants · Phase 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NCT05523947 · 147 participants · Phase 1
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- NCT06121843 · 147 participants · Phase 1
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia